drugset / Trial / NCT04378010
A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH
RandomizedParallel-groupTriple-blindTreatment
Summary
A randomized, double-blind study to assess the safety and efficacy of EDP-305 in subjects with liver-biopsy proven Non-Alcoholic Steatohepatitis (NASH)
Timeline
- Start
- 2020-01-27
- Primary completion
- 2021-10-04
- Completion
- 2021-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EDP-305 | Unknown | 1.5 mg | Oral |
| Subject | EDP-305 | Unknown | 2 mg | Oral |